[1] Sargis RM,Subbaiah PV.Protection of membrane cholesterol by sphingomyelin against free radical-mediated (nidation.Free Radic Biol Med,2006,40(12):2092-2102.
[2] Stadtman ER,Levine RL Free radical-mediated oxidation of free amino acids and amino acid residues in proteins.Amino Acids,2003,25(3^4):207-218.
[3] Dizdaroglu M,Jaruga P,Birincioglu M,et al.Free radical-induced damage to DNA:mechanisms and measurement.Free Radic Biol Med,2002,32(11):1102-1115.
[4] Ademoğlu E,Ozbey N,Erbil Y,et al.Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease.Eur J Intern Med,2006,17(8):545-550.
[5] Duthoit C,Estienne V,Giraud A,et al.Hydrogen peroxide-induced production of a 40 kDa iramunoreactive thyroglobulin fragment in human thyroid cells:the onset of thyroid autoimmunity?,Biochem J,200U360(pt 3):557-562.
[6] Komosinska-Vassev K,Olczyk K,Kucharz EJ,et al.Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy.Clin Chim Acta,2000,300(1-2):107-117.
[7] Bednarek J,Wysocki H,Sowiński J.Oxidative stress peripheral parameters in Graves' disease:the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.Clin Biochem,2005,38(1):13-18.
[8] Mayer L,Romić Z,Skreb F,et al.Antioxidants in patients with hyperthyroidism.Clin Chem Lab Med,2004,42(2):154-158.
[9] Abalovich M,Uesuy S,Gutierrez S,et al.Peripheral parameters of oxidative stress in Graves' disease:the effects of methimazole and 131iodine treatments.Clin Endocrinol,2003,59(3):321-327.
[10] Fcmdndcz V,Cornejo P,Tapia G, et al.Influence of hyperthyroidism on the activity of liver nitric oxide synthase in the rat.Nitric Oxide,1997,1(6):463-468,.
[11] Colin IM,Kopp P,Zbären J,et al.Expression of nitric oxide synthase III in human thyroid follicular cells:evidence for increased expression in hyperthyroidism.Eur J Endocrinol,1997,136(6):649-655.
[12] López-Moratalla N,Calleja A,González A,et al.Inducible nitric oxide synthase in monocytes from patients with Graves' disease.Biochem Biophys Res Commun,1996,226(3):723-729.
[13] Gérard AC,Boucquey M,van den Hove MF,et al.Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-lalpha/IFN-gamma,an effect partially mediated by nitric oxide.Am J Physiol Endocrinol Metab,2006,291(2):242-253.
[14] Kiotz LO,Schroeder P,Sies H.Peroxynitrite signaling:receptor tyrosine kinases and activation of stress-responsive pathways.Free Hadic Biol Med,2002,33(6):737-743.
[15] Alturfan AA,Zengin E,Dariyerli N,et al.Investigation of zinc and copper levels in methimazole-induced hypothyroidism:relation with the oxidant-antioxidant status.Folia Biol (Praha),2007,53(5):183-188.
[16] Hondur A,Konuk O,Dincel AS,et al.Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy. Cuit Eye Res,2008,33(5):421-427,.
[17] Mogulkoc R,Baltaci AK,Oztekin E,et al.Melatonin prevents oxidant damage in various tissues of rats with hyperthyroidism.Life Sci,2006,79(3):311-315.
[18] Moreno JM,Rodríguez Gómezl,Wangenstcen R,et al.Cardiac and renal antioxidant enzymes and effects of tcmpol in hyperthyroid rats.Am J Physiol Endocrinol Metab,2005,289(5):E776-E783.
[19] Dani V,Dhawan D.Zinc as an antiperoxidative agent following iodine-131 induced changes on the antioxidant system and on the morphology of red blood cells in rats.Hell J Nucl Med,2006,9(1):22-26.
[20] Agote Robertson M,Finochietto P,Gamba CA,et al.Nicotinamide increases thyroid radiosensitivity by stimulating nitric oxide synthase expression and the generation of organic peroxides.Horm Metab Res,2006,38(1):12-15.